BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16239206)

  • 21. Evaluation of the parathyroid function in six patients with hypophosphatemic osteomalacia, including a case of tertiary hyperparathyroidism developing during combined oral phosphate and vitamin D therapy.
    Jeon HJ; Kwon SH; Kim SW; Shin CS; Park KS; Kim SY; Cho BY; Lee HK
    Horm Res; 2003; 60(3):127-33. PubMed ID: 12931040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemangiopericytoma-induced osteomalacia: tumor transplantation in nude mice causes hypophosphatemia and tumor extracts inhibit renal 25-hydroxyvitamin D 1-hydroxylase activity.
    Miyauchi A; Fukase M; Tsutsumi M; Fujita T
    J Clin Endocrinol Metab; 1988 Jul; 67(1):46-53. PubMed ID: 2837500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal osteodystrophy in dialysis patients: diagnosis and treatment.
    Fournier A; Oprisiu R; Hottelart C; Yverneau PH; Ghazali A; Atik A; Hedri H; Said S; Sechet A; Rasolombololona M; Abighanem O; Sarraj A; El Esper N; Moriniere P; Boudailliez B; Westeel PF; Achard JM; Pruna A
    Artif Organs; 1998 Jul; 22(7):530-57. PubMed ID: 9684690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case of normocalcemic primary hyperparathyroidism with osteomalacia.
    Shimada I; Inaba M; Nakano H; Miki T; Nishizawa Y; Morii H
    Endocrinol Jpn; 1986 Oct; 33(5):575-82. PubMed ID: 3830067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Vitamin-resistant rickets cured by removal of a bone tumor. Review of the literature].
    François S; Lefort G; Poli-Merol ML; Gaillard D; Roussel B; Sulmont V; Daoud S
    Rev Chir Orthop Reparatrice Appar Mot; 1997; 83(4):387-92. PubMed ID: 9452815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osteomalacia and secondary hyperparathyroidism after kidney transplantation: Relationship to vitamin D deficiency.
    Amin H; Wall BM; Cooke CR
    Am J Med Sci; 2007 Jan; 333(1):58-62. PubMed ID: 17220696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone densitometry in a patient with hypophosphatemic osteomalacia.
    Negri AL; Bogado CE; Zanchetta JR
    J Bone Miner Metab; 2004; 22(5):514-7. PubMed ID: 15316875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphaturic mesenchymal tumor, mixed connective tissue variant (oncogenic osteomalacia).
    Tsujimura T; Sakaguchi K; Aozasa K
    Pathol Int; 1996 Mar; 46(3):238-41. PubMed ID: 10846577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitamin D metabolism and osteomalacia in cystic fibrosis.
    Friedman HZ; Langman CB; Favus MJ
    Gastroenterology; 1985 Mar; 88(3):808-13. PubMed ID: 3871414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitamin D deficiency osteomalacia triggered by long-term social withdrawal and unbalanced diet in a Japanese middle-aged subject: A case report.
    Iwamoto Y; Tatsumi F; Dan K; Katakura Y; Shimoda M; Kimura T; Nakanishi S; Mune T; Kaku K; Kaneto H
    Medicine (Baltimore); 2022 Jan; 101(2):e28589. PubMed ID: 35029240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced serum levels of 1 alpha,25-dihydroxyvitamin D during long-term total parenteral nutrition.
    Klein GL; Horst RL; Norman AW; Ament ME; Slatopolsky E; Coburn JW
    Ann Intern Med; 1981 May; 94(5):638-43. PubMed ID: 6786151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistent tumor-induced osteomalacia confirmed by elevated postoperative levels of serum fibroblast growth factor-23 and 5-year follow-up of bone density changes.
    Zimering MB; Caldarella FA; White KE; Econs MJ
    Endocr Pract; 2005; 11(2):108-14. PubMed ID: 15901526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitamin D resistant hypophosphatemic osteomalacia associated with osteosarcoma of the mandible: report of a case.
    Nomura G; Koshino Y; Morimoto H; Kida H; Nomura S; Tamai K
    Jpn J Med; 1982 Jan; 21(1):35-9. PubMed ID: 6279944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hypophosphatemic osteomalacia in adults].
    Löhr-Schwaab S; Wanner C; Reinbold WD; Schümichen C; Schölmerich J; Schaefer HE; Gerok W
    Dtsch Med Wochenschr; 1989 Apr; 114(14):538-42. PubMed ID: 2702931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor-induced osteomalacia: pre- and postoperative biochemical findings.
    Leicht E; Biro G; Langer HJ
    Horm Metab Res; 1990 Dec; 22(12):640-3. PubMed ID: 1963876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased catabolism of 25-hydroxyvitamin D in patients with partial gastrectomy and elevated 1,25-dihydroxyvitamin D levels. Implications for metabolic bone disease.
    Davies M; Heys SE; Selby PL; Berry JL; Mawer EB
    J Clin Endocrinol Metab; 1997 Jan; 82(1):209-12. PubMed ID: 8989260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent advances in pediatric metabolic bone disease: the consequences of altered phosphate homeostasis in renal insufficiency and hypophosphatemic vitamin D-resistant rickets.
    Pettifor JM
    Bone Miner; 1990 Jun; 9(3):199-214. PubMed ID: 2163713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal hypophosphatemic osteomalacia unmasked by hyperthyroidism.
    Baranetsky NG; Chertow BS; Sivitz WI; Mullen JO
    Am J Med Sci; 1986 Oct; 292(4):231-4. PubMed ID: 3019139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor-induced osteomalacia: lessons learned.
    Lewiecki EM; Urig EJ; Williams RC
    Arthritis Rheum; 2008 Mar; 58(3):773-7. PubMed ID: 18311810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osteomalacia as a very late manifestation of primary hyperparathyroidism.
    Kaplan FS; Soffer SR; Fallon MD; Haddad JG; Dalinka M; Raffensperger EC
    Clin Orthop Relat Res; 1988 Mar; (228):26-32. PubMed ID: 3342577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.